Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Excess mortality in Europe estimated by EuroMOMO during the COVID-19 pandemic and previous influenza seasons.

Nature communications·2026
Same author

Knowledge gaps and research priorities regarding vaccination in pregnancy: A Canadian perspective from the prevention of infections in the maternal-infant dyad (PRIMED) consortium.

Vaccine·2025
Same author

Measles seroprevalence among individuals serologically tested in Ontario, Canada.

Vaccine·2025
Same author

What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health Organization.

Vaccine·2025
Same author

Economic analysis of 15-valent and 20-valent pneumococcal conjugate vaccines among older adults in Ontario, Canada.

Expert review of vaccines·2025
Same author

Global challenges and solutions to achieving and sustaining measles and rubella elimination.

Revista panamericana de salud publica = Pan American journal of public health·2024

Video Experimental Relacionado

Updated: Jul 6, 2026

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

Desarrollos recientes en la tos ferina.

Natasha S Crowcroft1, Richard G Pebody

  • 1Immunisation Department, Health Protection Agency Centre for Infections, London NW9 5EQ, UK. Natasha.Crowcroft@HPA.org.uk

Lancet (London, England)
|June 13, 2006
PubMed
Resumen

La vacunación contra la tos ferina es crucial para los niños, pero se producen infecciones punteras. Se están explorando nuevas estrategias, incluidos los refuerzos y la vacunación de las mujeres embarazadas, para combatir esta enfermedad respiratoria persistente.

Más Videos Relacionados

A Preliminary Study on Warm Acupuncture and Moxibustion for Treating Chronic Obstructive Pulmonary Disease with Abdominal Distension
05:19

A Preliminary Study on Warm Acupuncture and Moxibustion for Treating Chronic Obstructive Pulmonary Disease with Abdominal Distension

Published on: September 1, 2023

Methods for Detecting Cough and Airway Inflammation in Mice
04:33

Methods for Detecting Cough and Airway Inflammation in Mice

Published on: August 2, 2024

Videos de Experimentos Relacionados

Last Updated: Jul 6, 2026

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

A Preliminary Study on Warm Acupuncture and Moxibustion for Treating Chronic Obstructive Pulmonary Disease with Abdominal Distension
05:19

A Preliminary Study on Warm Acupuncture and Moxibustion for Treating Chronic Obstructive Pulmonary Disease with Abdominal Distension

Published on: September 1, 2023

Methods for Detecting Cough and Airway Inflammation in Mice
04:33

Methods for Detecting Cough and Airway Inflammation in Mice

Published on: August 2, 2024

Área de la Ciencia:

  • Salud Pública La salud pública.
  • Enfermedades infecciosas Enfermedades infecciosas.
  • Vacunología Vacunología.

Sus antecedentes:

  • La tos ferina sigue siendo una importante amenaza para la salud mundial, causando cientos de miles de muertes infantiles anualmente, particularmente en los países en desarrollo.
  • Si bien la vacunación contra la tos ferina es efectiva en bebés y niños, las infecciones innovadoras en individuos vacunados destacan los desafíos en curso.
  • El control de la tos ferina es complejo, con cuestiones que van desde mejorar la cobertura de vacunación en regiones de alta mortalidad hasta manejar el aumento de casos en adolescentes y adultos en áreas bien vacunadas.

Objetivo del estudio:

  • Revisar los desafíos actuales y las estrategias emergentes en el control y la prevención de la tos ferina.
  • Para resaltar las incertidumbres en la dinámica de transmisión de la tos ferina y la necesidad de mejorar los datos.
  • Discutir nuevos enfoques de vacunación para mejorar la inmunidad de la población contra la tos ferina.

Principales métodos:

  • Revisión de la literatura existente sobre la epidemiología de la tos ferina, el impacto de la vacunación y los programas de control.
  • Análisis de las tendencias en la incidencia de la tos ferina en diferentes grupos de edad y entornos geográficos.
  • Examen de las estrategias de vacunación actuales y propuestas, incluidas las dosis de refuerzo y las nuevas poblaciones objetivo.

Principales resultados:

  • La vacunación contra la tos ferina reduce significativamente la mortalidad y las hospitalizaciones en niños, sin embargo, los desafíos persisten a nivel mundial.
  • Se han reportado aumentos en los casos de tos ferina entre adolescentes, adultos y bebés no vacunados, aunque el alcance se debate.
  • Actualmente se desconoce la efectividad de los nuevos programas de refuerzo para adolescentes y adultos debido a los datos limitados.

Conclusiones:

  • A pesar de la alta cobertura de vacunación en algunas regiones, la tos ferina sigue siendo una enfermedad infantil difícil de controlar.
  • Las brechas en los datos clave, particularmente con respecto a la transmisión de adultos a bebés, dificultan el diseño óptimo del programa de vacunación.
  • Se están investigando estrategias innovadoras, como la vacunación de mujeres embarazadas, recién nacidos y contactos familiares, para mejorar el control de la tos ferina.